Oncology/Hematology
Chemotherapy
More in Chemotherapy
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
News, features, and commentary about cancer-related issues
News, features, and commentary about cancer-related issues
News, features, and commentary about cancer-related issues
Three cycles could become the new standard for retinoblastoma, researchers say
-- News, features, and commentary about cancer-related issues
News, features, and commentary about cancer-related issues
Other studies look at financial toxicity for teen/young adult cancer patients, nausea after chemo
Meta-analysis points to considerations for use and what to monitor
"This is sort of the dirty underbelly of the current healthcare environment," an oncologist said
No difference in overall survival with versus without bolus, less toxicity without
News, features, and commentary about cancer-related issues
Troublesome side effects, barriers to access could limit future availability
News, features, and commentary about cancer-related issues
